loader2
Partner With Us NRI

Jun 24, 2022

Category

Equity

AUM (Cr.)

158.90

Exit Load (%)

1.00

Min Inv Lumpsum

5,000

Expense Ratio

2.52

Sharpe Ratio

-10.92

Beta Ratio

0.00

Fund Manager

Rohan Korde

Inception Date

Nov 08, 2021

Risk Level

Very High

Investment Objective

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.

Invest Now
NIFTY Healthcare TRI

Return Calculator

Investment Type

SIP Lumpsum

Company

Period(Year)

Amount

  • periodic returns
  • Peer Comparison
Returns Type 1 Month (%) 6 Months (%) 1 Year (%) 3 Years (%) 5 Years (%) Since Inception (%)
Scheme - ITI Pharma and Healthcare Fund (G) -1.64 -11.8 0 0 0 -13.62
Benchmark - NIFTY Healthcare TRI 0 0 0 0 0 0
Category Average - BEST EQUITY PERFORMERS -2.92 -9.59 -1.67 13.14 9.54 10.04
Category Rank 7/8 5/8 9/8 7/8 8/8 8/8
Fund Name Nav () Chg (%) 1Y Return(%) 3Y Return(%) 5Y Return(%) AUM ( in Crs) Exp. Ratio (%) Min.Invst() Action
ICICI Pru US Bluechip Equity Fund (G) 41.9300 3.79 -10.00 13.67 13.82 1,975.79 2.14 5,000.00 invest
ICICI Pru US Bluechip Equity Fund (IDCW) 41.9300 3.79 -10.00 13.67 13.82 1,975.79 2.14 5,000.00 invest
Nippon India US Equity Opportunities Fund (IDCW) 21.7847 3.25 -15.20 9.88 12.90 523.78 2.49 100.00 invest
Nippon India US Equity Opportunities Fund (G) 21.7847 3.25 -15.20 9.88 12.90 523.78 2.49 100.00 invest
SBI Magnum Equity ESG Fund (IDCW) 45.6392 -89.21 -0.55 10.90 10.37 4,246.33 1.97 1,000.00 invest

Asset Allocation

Val (Cr.) Allocation (%)

Top sectors

AUM in Cr.

top holdings

Company Name As on Date Invested Amt (Cr) % Portfolio Weight Change (%)
(Invested Amt.)		 4 Months Trends
Equity-Sun Pharma.Inds. May 31, 2022 31.95 20.10 -11.14
Equity-Torrent Pharma. May 31, 2022 12.65 7.96 -11.29
Equity-Lupin May 31, 2022 12.33 7.76 -19.16
Equity-Dr Reddy`s Labs May 31, 2022 9.72 6.12 3.11
Equity-Divi`s Lab. May 31, 2022 9.43 5.94 -22.21
Equity-Cipla May 31, 2022 9.17 5.77 35.27
Equity-Glaxosmi. Pharma May 31, 2022 8.03 5.05 -6.42
Equity-Natco Pharma May 31, 2022 7.12 4.48 -14.39
Equity-Alkem Lab May 31, 2022 5.73 3.61 -7.20
Equity-Astec Lifescienc May 31, 2022 5.69 3.58 -0.97

latest news

ITI MF Announces change exit load structure under its schemes

ITI Mutual Fund has announced change in exit load structure under the follo...

Sep 28, 2021 11:41

ITI Dynamic Bond Fund Announces change in exit load structure

ITI Mutual Fund has announced change in exit load structure under ITI Dynam...

Aug 19, 2021 12:44

ITI Ultra Short Duration Fund Announces Extension of NFO period

ITI Mutual Fund has announced the closing date of the New Fund Offer (NFO) ...

Apr 19, 2021 11:28

ITI MF Announces Appointment of Fund Manager and Key Personnel

ITI Mutual Fund has announced that Rohan Korde has been appointed as thr Co...

Feb 24, 2021 13:35

ITI MF Announces change in benchmark indices under two schemes

ITI Mutual Fund has announced change the benchmark index for the following ...

Jan 01, 2021 12:48

ITI Mutual Fund Announces Dividend under two schemes

ITI Mutual Fund has announced 22 December 2020 as the record date for decla...

Dec 17, 2020 13:04

SCHEME DETAILS

AMC Name : ITI Mutual Fund
Fund Name : ITI Pharma and Healthcare Fund (G)
Contact Persone : Rohan Korde
Registered Address : ITI House 36, Dr.R.K.Shirodkar Marg,Parel Mumbai - 400012,400013
Telephone No : 022-66214999
Fax No. : 022-66214998
Email : mfassist:itiorg.com
Website : www.itimf.com